Your browser doesn't support javascript.
loading
Targeting epigenetic mechanisms to overcome venetoclax resistance.
Prado, Gabriel; Kaestner, Charlotte L; Licht, Jonathan D; Bennett, Richard L.
Afiliação
  • Prado G; University of Florida Health Cancer Center and University of Florida Department of Medicine, Division of Hematology and Oncology, Gainesville, FL 32610, United States of America.
  • Kaestner CL; University of Florida Health Cancer Center and University of Florida Department of Medicine, Division of Hematology and Oncology, Gainesville, FL 32610, United States of America.
  • Licht JD; University of Florida Health Cancer Center and University of Florida Department of Medicine, Division of Hematology and Oncology, Gainesville, FL 32610, United States of America.
  • Bennett RL; University of Florida Health Cancer Center and University of Florida Department of Medicine, Division of Hematology and Oncology, Gainesville, FL 32610, United States of America. Electronic address: bennettr@ufl.edu.
Biochim Biophys Acta Mol Cell Res ; 1868(8): 119047, 2021 07.
Article em En | MEDLINE | ID: mdl-33945824
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Resistencia a Medicamentos Antineoplásicos / Compostos Bicíclicos Heterocíclicos com Pontes / Epigênese Genética / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Biochim Biophys Acta Mol Cell Res Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Resistencia a Medicamentos Antineoplásicos / Compostos Bicíclicos Heterocíclicos com Pontes / Epigênese Genética / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Biochim Biophys Acta Mol Cell Res Ano de publicação: 2021 Tipo de documento: Article